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Treatment of a type IIIb endoleak in a Talent
endograft using telescoping cuffs and two parallel
upside-down excluder contralateral legs
Michel M. P. J. Reijnen, MD, PhD,a David J. Minion, MD,b and
Jan Willem H. P. Lardenoye, MD, PhD,a Arnhem, The Netherlands; and Lexington, Ky
We describe a case of a type IIIb endoleak arising from the main body of a Talent endograft that was treated using two
telescoping cuffs and two parallel upside-down inserted Excluder contralateral legs, thereby creating a new bifurcating
endograft. First, a 23-mm cuff was deployed onto the flow divider of the Talent endograft, followed by a second 28-mm
cuff below the renal arteries creating a tapering lumen. Two 20-mm Excluder contralateral limbs were then positioned
upside-down in the 23-mm cuff and deployed simultaneously, creating a new bifurcated prosthesis. Control computed
tomography (CT) scan at 6 weeks showed a good position of the endografts without signs of an endoleak. In conclusion,
a type IIIb endoleak at the level of the flow divider may successfully be excluded using two telescoping cuffs and two
parallel upside-down contralateral Excluder limbs. Due to the rarity of this complication, the treatment will always have
to be tailor-made. (J Vasc Surg 2012;56:538-41.)
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nThe principal drawback of endovascular aneurysm
repair (EVAR) is the rate of secondary interventions in
order to treat endoleak, endograft migration, graft dis-
connection, stent fractures, or graft thrombosis. En-
doleaks are the most important reason for failure of
EVARs and treatment depends on the type and conse-
quence (eg, aneurysmal sac enlargement). Transgraft
endoleaks, referred to as type III endoleaks, may be
caused either by a disconnection of components of a
modular endograft system (IIIa) or by a defect in the
stent-covering graft fabric (IIIb).1,2 Previous studies
have reported an incidence of type III endoleaks ranging
from 0.7% to 7%.3-5 Whether the incidence will increase
or decrease with newer, but lower profile endograft
designs is unknown. Similar to type I endoleaks, a type
III endoleak is considered to warrant early correction
once detected, as they allow direct pressurization of the
sac which can lead to aneurysm growth and rupture.6-8
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538The Talent endograft (Medtronic, Santa Rosa, Calif) is
ne of the most frequently used devices worldwide and
ombines suprarenal fixation with high radial force with
olumnar strength. Verhoeven et al9 have recently de-
cribed the long-term outcome of this endograft and found
primary clinical success rate of 98% at 1 year and 48% at 7
ears. Secondary interventions were performed in 20% of
atients during follow-up, but they described only one type
II endoleak (0.3%). We describe a case of a type IIIb
ndoleak arising from the main body of a Talent endograft,
reviously extended with a proximal cuff for a type I en-
oleak, that was treated using two telescoping aortic cuffs
nd two parallel upside-down inserted Excluder (W. L.
ore, Flagstaff, Ariz) contralateral legs, thereby creating a
ew bifurcating endograft inside the Talent endograft.
ASE REPORT
A 77-year-old patient, with a history of a Bell’s palsy,
ypertension, and a left-sided below-knee femoropopliteal by-
ass, was treated by EVAR for an abdominal aneurysm using a
ifurcated Talent endograft (AF2820C120AX) 4 years earlier.
t the time of treatment, the Talent endograft was the preferred
ndograft in our institution. After an initial good result, a
roximal type I endoleak occurred after 3 years which was
aused by a 13-mm distal migration and related to a 9-mm
neurysm growth. The endoleak was successfully treated
ith a proximal aortic cuff (ENCF3232C45EE, Endurant;
edtronic). The Endurant cuff was chosen for optimal suprare-
al fixation with barbs. However, 1 year afterward, a new
ndoleak occurred related to a further 4-mm aneurysm growth
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Volume 56, Number 2 Reijnen et al 539to 66 mm, as confirmed by computed tomography (CT) scan.
The CT scan, however, did not clearly show the origin of the
endoleak. Subsequent digital subtraction angiography showed a
type IIIb endoleak at the level of the flow divider near the distal
end of the Endurant cuff (Fig 1). The location of the endoleak,
at the level of the flow divider, would render a solution with
another aortic cuff likely to be ineffective. The distance from the
lower margin of the renal arteries to the flow divider was 53 mm,
rendering a solution with a new bifurcated above the flow
divider impossible. A conversion to either an open repair or to a
mono-iliac endograft with a femorofemoral crossover bypass
was considered to be unfavorable due to multiple previous
operations in the groin. Therefore, we chose to exclude the
endoleak by building up a new bifurcated prosthesis using two
converting aortic cuffs and two parallel upside-down contralat-
eral limbs. In our opinion, the lack of optimal alternatives
justified the off-label use of devices in this case.
The patient was operated upon while under regional anesthe-
sia and received 5000 IU heparin and 1 gram cefazolin intrave-
nously. Both common femoral arteries were surgically exposed to
position an angiography catheter in the suprarenal aorta and to
insert a 23-mm proximal cuff (Excluder; W. L. Gore) into the body
of the Talent endograft. Subsequently, it was deployed just above
the flow divider. Then, a second 28-mm cuff was introduced and
Fig 1. Digital subtraction angiography showing a type IIIb en-
doleak at the level of the flow divider of the Talent endograft. The
endoleak is rising from an area just below the lower margin of the
Endurant aortic cuff.temporarily placed in the suprarenal aorta. The first cuff was then tetracted onto the flow divider using a balloon catheter (Reliant;
edtronic). Afterward, the second cuff was retracted and deployed
mmediately below the renal arteries in themain body of the Talent
ndograft, overlapping with the 23-mm cuff. Subsequently, two
xcluder contralateral limbs, with a distal diameter of 20mm, were
ositioned upside-down, as previously described.10 Briefly, the
ontralateral limbs were disconnected from the delivery catheter.
he olives at the end of the catheter were removed, the deploy-
ent knobs unscrewed, and the deployment lines were cut. Then,
he sleeved prosthesis was removed from the catheter and intro-
uced upside-down in two 18F introducer sheaths. To create a
usher, approximately 1 cm of the tip of each 18F sheath’s dilators
as cut. The prosthesis was now positioned and deployed within
he sheaths. Subsequently, the endografts were simultaneously
eployed in the 23-mm cuff by retracting the sheaths over the
ilators while keeping the dilators in place, thereby creating a new
ifurcated prosthesis (Fig 2, a and b). Control angiography
howed a good position of the endografts, patent renal arteries,
nd no signs of a residual endoleak (Fig 3). The postoperative
ourse was uneventful and the patient was discharged from the
ospital at day 4 in good ambulatory condition.He is being treated
ith acetylsalicylic acid 80 mg for life.
At 6 weeks, a duplex ultrasound revealed no signs of endoleak
nd a good apposition of all individual stent grafts. A complemen-
ary CT angiography showed a patent endograft without an en-
oleak and a stable diameter of the aneurysm. Transverse cuts of
ig 2. a and b, The newly developed bifurcated prosthesis show-
ng a complete fit of the two 20-mm endografts in the 23-mm
ortic cuff, without leaving gutters.he CT scan at the level of the upside-down inserted contralateral
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August 2012540 Reijnen et allimbs showed complete apposition to the 23-mm cuff by the two
limbs with no gutters (Fig 4).
DISCUSSION
In the present report, we describe a case of a type IIIb
endoleak that was excluded by using two telescoping aortic
cuffs and two upside-down inserted Excluder contralateral
legs. The design of this configuration was based on math-
ematics. When using two parallel limbs to create a seal
Fig 3. Completion angiography showing an adequate deploy-
ment and position of the endografts and a resolved endoleak.
Fig 4. Control computed tomography (CT) angiography show-
ing a good deployment of the two upside-down inserted Excluder
limbs that completely fill the 23-mm aortic cuff.inside of a single lumen, appropriate sizing depends on the whape that limbs will assume. When the limbs are of equal
ize, then the desired shape is back-to-back or “doubleDs.”
he curved portion, each D-shaped, is a perfect semicircle
qualing half the circumference of the main graft. The
traight portion of each D-shape is equivalent to the diam-
ter of the main graft. Therefore, to fill this shape, the
ircumference of each parallel limb must be at least half the
ircumference plus one diameter of the main graft. Circum-
erence equals  * diameter, thus solving for diameter, the
arallel limbsmust be at least ( 2)/( * 2) times the size
f the main graft, or approximately 82%. By deploying
he Excluder limbs upside-down, we were able to utilize
he 20-mm diameter portion of the limbs for the double
s. This was only possible using Excluder limbs inserted
pside-down, which justified the off-label use. However,
hat would still not have been enough to seal the 28-mm
iameter Talent graft. Therefore, we first placed the tele-
coping aortic cuffs to effectively reduce the diameter of the
ain body to 23 mm. As such, we were able to achieve seal,
s confirmed by our postoperative imaging.
The main reason for choosing this strategy was the risk
f failure of other possible endovascular techniques. Be-
ause the defect was located at the level of the flow splitter,
he use of an aortic cuff only was considered to be prone for
ailure, as the endograft was likely to be placed above the
efect. Another choice could have been the insertion of a
ompletely new Excluder bifurcated graft using the C3
elivery system. It would have been necessary to initially
eploy the graft above the renal arteries; but with the
roximal end reconstrained, it might have been possible to
hen retract the graft into the old Talent endograft. How-
ver, the diameter of the expanded contralateral leg of the
xcluder (13 mm) was too large to be retracted into the
ontralateral leg of the Talent endograft (12 mm) without
rst compressing it with a snare. We were not certain of the
easibility of this maneuver and felt it risked renal ischemia.
onversion to a mono-iliac device would have been an-
ther option.11 Using that strategy, however, a femoro-
emoral crossover bypass would have been requisite, which
as considered to be unfavorable due to multiple previous
perations in the groin. A last, but experimental, solution
ould have been sealing the defect by injecting biocompat-
ble elastomer, as was recently described.12
A type IIIb endoleak is an extremely rare complication.
he reason why the endoleak occurred in our patient
emains unclear. However, there seemed to be a close
elation with the lower margin of the proximal cuff that was
nserted 1 year earlier for a type I endoleak. The fabric may
ave been damaged during that secondary procedure or by
he stent material of the cuff.
In conclusion, we have shown that a type IIIb endoleak
t the level of the flow divider has successfully been ex-
luded using two telescoping aortic cuffs and two parallel
pside-down contralateral Excluder limbs. Due to the rar-
ty of this complication, larger series will never be available
nd, therefore, the solution for this complication will al-
ays have to be tailor-made.
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